Clinical significance and biological function of interferon regulatory factor 1 in non-small cell lung cancer

The clinical application and biological function of interferon regulatory factor 1 (IRF1) in non-small cell lung cancer (NSCLC) patients undergoing chemoimmunotherapy remain elusive. The aim of this study was to investigate the predictive and prognostic significance of IRF1 in NSCLC patients. We emp...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jialin Su, Shuhua Tan, Yuning Li, Xinglong Chen, Jiasi Liu, Yongzhong Luo, Changqie Pan, Lemeng Zhang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-06-01
Edice:	Frontiers in Pharmacology
Témata:	interferon regulatory Factor-1 non-small cell lung cancer interleukin-2 chemoimmunotherapy inflammatory pathway
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1413699/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!